Cost-effectiveness
Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study
Lyth J, Svennberg E, Bernfort L, Aronsson M, Frykman V, Al-Khalili F, Friberg L, Rosenqvist M, Engdahl J, Levin L-Å.
European Heart J, 2023.
Cost-effectiveness of screening for atrial fibrillation in a single primary care center at a 3-year follow-up
Ghazal F, Aronsson M, Al-Khalili F, Rosenqvist M & Levin L-Å.
Scandinavian cardiovascular journal, 2022.
A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke
Levin L, Husberg M, Doliwa Sobocinski P, Frykman Kull V, Friberg L, Rosenqvist M & Davidson T.
Europace, 2014.
Assessment Regarding Primary Preventive Screening of Atrial Fibrillation with Thumb ECG
Tandvårds- och läkemedelsförmånsverket, 2014.
Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording
Aronsson M, Svennberg E, Rosenqvist M, Engdahl J, Al-Khalili F, Friberg L, Frykman-Kull V & Levin L-Å.
Europace, 2015.
